The news of Morgan Stanley maintaining an Equal-Weight rating on Primerica and raising the price target from $162 to $170 indicates that the analyst sees potential for the stock price to increase. However, the Equal-Weight rating suggests that the stock is expected to perform in line with the market, which means the short-term impact on the stock price is neutral.